School mask policies and SARS-CoV-2 seroprevalence among school-age children-United States, September to December 2021

被引:0
|
作者
Nycz, Elise [1 ]
Deng, Yangyang [2 ]
Van Dyke, Miriam E. [1 ]
Bratcher, Anna [1 ]
Shi, Jianrong [1 ]
Iachan, Ronaldo [2 ]
Berney, Kevin [3 ]
Jones, Jefferson M. [1 ]
Clarke, Kristie E. N. [1 ]
机构
[1] CDCP, COVID 19 Response Team, Atlanta, GA 30333 USA
[2] Agcy Tox Subst & Dis Registry, ICF, Atlanta, GA USA
[3] Agcy Tox Subst & Dis Registry, Geospatial Res Anal & Serv Program GRASP, Atlanta, GA USA
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 10期
关键词
immunology; immunoserology; seroprevalence; SARS-CoV-2; masks; schools; pediatric infectious disease; public health; ELEMENTARY-SCHOOLS; TRANSMISSION; COUNTY; INFECTION;
D O I
10.1128/spectrum.00691-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During September to December 2021, school mask policies to mitigate SARS-CoV-2 transmission varied throughout the US. We compared infection-induced seroprevalence estimates and estimated seroconversion among children residing in areas with and without school mask requirements. We estimated infection-induced seroprevalence among children in three age groups (5-17, 5-11, and 12-17 years) in areas with and without school district mask requirements for two time points: September 1-30, 2021 and December 15, 2021 to January 14, 2022. Robust Poisson regression models estimated population seroconversion over the semester among initially seronegative children. Permutation tests assessed for significant differences in the estimated population seroconversion due to incident infections by school district mask policy. Residing in an area with no school mask requirement was associated with higher infection-induced seroprevalence among children aged 5-17 years (adjusted prevalence ratio [aPR] = 1.18, 95% confidence interval [CI]: 1.10, 1.26), and those aged 5-11 years (aPR) = 1.21, 95% CI: 1.10, 1.32) and those aged 12-17 years (aPR = 1.16, 95% CI: 1.07, 1.26), compared with areas requiring masks in school. Estimated population seroconversion during the semester was also significantly higher among children in districts without mask policies than those with school mask requirements among all age groups (5-17 years: 23.7% vs 18.1%, P < 0.001; 5-11 years: 6.4% vs 4.5%, P = 0.002;12-17 years: 27.2% vs 21.0%, P < 0.001). During the U.S. Fall 2021 semester, areas with school mask requirements had lower infection-induced seroprevalence and an estimated lower proportion of seroconversion due to incident infection among school-aged children compared with areas without school mask requirements; causality cannot necessarily be inferred from these associations. IMPORTANCE During the U.S. Fall 2021 school semester, the estimated proportion of previously uninfected school-aged children who experienced a first infection with SARS-CoV-2 was lower in areas where public school district policies required masks for all staff and students compared with areas where the school districts had no mask requirements. Because children are more likely than adults to experience asymptomatic or mild SARS-CoV-2 infections, the presence of infection-induced antibodies is a more accurate measure of infection history than clinical testing. The proportion of children with these antibodies (i.e., seroprevalence) can improve our understanding of SARS-CoV-2 by detecting more infections and eliminating potential bias due to local testing and reporting practices. Enhanced robustness of surveillance for respiratory infections in children, including records of mitigation policies in communities and schools, as well as seroprevalence data, would establish a better evidence base for policy decisions and response measures during future respiratory outbreaks.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period
    Dimitra Dimopoulou
    Despoina Sotiri
    Dimitra Kousi
    Garyfallia Loulou
    Kalliopi Raptaki
    Ariadni Neofytou
    Foteini Dasoula
    Maria Tampouratzi
    Athina Koloi
    Eirini Eleftheriou
    Eleni Vergadi
    Eleni Papadimitriou
    Irini Zorbadaki
    Artemis Mavridi
    Konstantinos Miliordos
    Evangelia Steletou
    Maria Strempela
    Paraskevi C. Fragkou
    Vassiliki Spoulou
    Athanasios Michos
    Despoina Gkentzi
    Vassiliki Papaevangelou
    Fani Ladomenou
    Ioanna Grivea
    George Syrogiannopoulos
    Emmanouil Galanakis
    Theoklis Zaoutis
    Kyriaki Tryfinopoulou
    Maria N. Tsolia
    European Journal of Pediatrics, 2024, 183 : 2491 - 2499
  • [32] Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Georgia School District-United States, December 2020-January 2021
    Gettings, Jenna R.
    Gold, Jeremy A. W.
    Kimball, Anne
    Forsberg, Kaitlin
    Scott, Colleen
    Uehara, Anna
    Tong, Suxiang
    Hast, Marisa
    Swanson, Megan R.
    Morris, Elana
    Oraka, Emeka
    Almendares, Olivia
    Thomas, Ebony S.
    Mehari, Lemlem
    McCloud, Jazmyn
    Roberts, Gurleen
    Crosby, Deanna
    Balajee, Abirami
    Burnett, Eleanor
    Chancey, Rebecca J.
    Cook, Peter
    Donadel, Morgane
    Espinosa, Catherine
    Evans, Mary E.
    Fleming-Dutra, Katherine E.
    Forero, Catalina
    Kukielka, Esther A.
    Li, Yan
    Marcet, Paula L.
    Mitruka, Kiren
    Nakayama, Jasmine Y.
    Nakazawa, Yoshinori
    O'Hegarty, Michelle
    Pratt, Caroline
    Rice, Marion E.
    Stewart, Roxana M. Rodriguez
    Sabogal, Raquel
    Sanchez, Emanny
    Velasco-Villa, Andres
    Weng, Mark K.
    Zhang, Jing
    Rivera, Grant
    Parrott, Tonia
    Franklin, Rachel
    Memark, Janet
    Drenzek, Cherie
    Hall, Aron J.
    Kirking, Hannah L.
    Tate, Jacqueline E.
    Vallabhaneni, Snigdha
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (02) : 319 - 326
  • [33] SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada
    Watts, Allison W.
    Masse, Louise C.
    Goldfarb, David M.
    Irvine, Mike A.
    Hutchison, Sarah M.
    Muttucomaroe, Lauren
    Poon, Bethany
    Barakauskas, Vilte E.
    O'Reilly, Collette
    Bosman, Else
    Reicherz, Frederic
    Coombs, Daniel
    Pitblado, Mark
    O'Brien, Sheila F.
    Lavoie, Pascal M.
    BMJ OPEN, 2023, 13 (06):
  • [34] Serosurvey for SARS-CoV-2 among blood donors in Wuhan, China from September to December 2019
    Chang, Le
    Zhao, Lei
    Xiao, Yan
    Xu, Tingting
    Chen, Lan
    Cai, Yan
    Dong, Xiaojing
    Wang, Conghui
    Xiao, Xia
    Ren, Lili
    Wang, Lunan
    PROTEIN & CELL, 2023, 14 (01) : 28 - 36
  • [35] SARS-CoV-2 PCR and antibody positivity among school staff at the beginning and end of the first school term
    Moza Alishaq
    Andrew Jeremijenko
    Hanaa Nafady-Hego
    Jameela Ali Al Ajmi
    Mohamed Elgendy
    Anil George Thomas
    Peter V. Coyle
    Hamed Elgendy
    Abdul-Badi Abou-Samra
    Adeel A. Butt
    BMC Public Health, 21
  • [36] Risk factors for SARS-CoV-2 infection in primary and secondary school students and staff in England in the 2020/2021 school year: a longitudinal study
    Nguipdop-Djomo, Patrick
    Oswald, William E.
    Halliday, Katherine E.
    Cook, Sarah
    Sturgess, Joanna
    Sundaram, Neisha
    Warren-Gash, Charlotte
    Fine, Paul E. M.
    Glynn, Judith
    Allen, Elizabeth
    Clark, Taane G.
    Ford, Benjamin
    Judd, Alison
    Ireland, Georgina
    Poh, John
    Bonell, Chris
    Dawe, Fiona
    Rourke, Emma
    Diamond, Ian
    Ladhani, Shamez N.
    Langan, Sinead M.
    Hargreaves, James
    Mangtani, Punam
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 128 : 230 - 243
  • [37] Prevalence of risk behaviors and correlates of SARS-CoV-2 positivity among in-school contacts of confirmed cases in a Georgia school district in the pre-vaccine era, December 2020–January 2021
    Marisa Hast
    Megan Swanson
    Colleen Scott
    Emeka Oraka
    Catherine Espinosa
    Eleanor Burnett
    Esther A. Kukielka
    Marion E. Rice
    Lemlem Mehari
    Jazmyn McCloud
    Danielle Miller
    Rachel Franklin
    Jacqueline E. Tate
    Hannah L. Kirking
    Elana Morris
    BMC Public Health, 22
  • [38] Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario
    Aglipay, Mary
    Kwong, Jeffrey C.
    Colwill, Karen
    Gringas, Anne-Claude
    Tuite, Ashleigh
    Mamdani, Muhammad
    Keown-Stoneman, Charles
    Birken, Catherine
    Maguire, Jonathon
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2024, 115 (06): : 913 - 923
  • [39] Within-household SARS-CoV-2 transmission and vaccine effectiveness in the first three COVID-19 school outbreaks in northern Viet Nam, September-December 2021
    Vu, Trang Thu
    Ngo, Tu Huy
    Nguyen, Khanh Cong
    Lan, Vu Thi
    Hanh, Cu Thi Bich
    Son, Le Hong
    Nguyen, Huyen Thi
    Nguyen, Hien Thi
    Ngu, Nghia Duy
    Tran, Duong Nhu
    Dang, Duc-Anh
    Vogta, Florian
    Pham, Thai Quang
    WESTERN PACIFIC SURVEILLANCE AND RESPONSE, 2024, 15 (03)
  • [40] Three-year seroprevalence of SARS-CoV-2 nucleocapsid protein antibody among children, parental awareness, and contributors of infection: a single-school cohort study in Chiba, Japan
    Yamamoto, Midori
    Sakurai, Kenichi
    Takatani, Rieko
    Hisada, Aya
    Mori, Chisato
    JOURNAL OF EPIDEMIOLOGY, 2024,